Eli Lilly and Company (LLY ... indicating a potential upside of 25.7% from the current levels. With headquarters in the heart of Chicago's financial district, Barchart has been an industry ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

That's among 35 predictions I'm offering for the new year, ranging from politics to business to sports. I've never published ...

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, including decreasing sales for certain kinds of foods.

Oil dropped from a five-month high as Hamas and Israel tentatively agreed to a cease-fire, cooling a rally fueled by risks to ...

Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty ...

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

A key milestone in 2024 was the start of construction on the Uline corporate headquarters office building ... A major announcement in December revealed Eli Lilly and Company plans to invest ...

Indiana University announced Friday that it’s raising pay for graduate students with part-time research or teaching duties, but the union representing the workers isn’t satisfied.